tiprankstipranks
Trending News
More News >
ESSA Pharma Inc. (EPIX)
:EPIX
US Market
Advertisement

ESSA Pharma (EPIX) Stock Forecast & Price Target

Compare
Followers
See the Price Targets and Ratings of:

EPIX Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
ESSA
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EPIX Stock 12 Month Forecast

There Are No Analyst Ratings for EPIX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

EPIX Financial Forecast

EPIX Earnings Forecast

The previous quarter’s earnings for EPIX were -$0.09.
The previous quarter’s earnings for EPIX were -$0.09.
No data currently available

EPIX Sales Forecast

The previous quarter’s earnings for EPIX were $0.00.
The previous quarter’s earnings for EPIX were $0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bloom Burton Analyst forecast on EPIX
Bloom Burton
Bloom Burton
$2.25
Hold
Initiated
12/16/24
Bloom Burton Co. assumes ESSA Pharma (EPIX) at Hold (3)Bloom Burton Co. analyst David Martin assumes coverage on ESSA Pharma (NASDAQ: EPIX) with a Hold (3) rating and a price target of $2.25.
Piper Sandler Analyst forecast on EPIX
Piper Sandler
Piper Sandler
$15$2
Hold
Downgraded
11/04/24
ESSA Pharma Downgraded to Hold Amid Masofaniten Trial Termination and Revised Financial Outlook
Oppenheimer Analyst forecast on EPIX
Oppenheimer
Oppenheimer
Hold
Downgraded
11/03/24
Oppenheimer downgrades ESSA Pharma (EPIX) to PerformOppenheimer analyst Leland Gershell downgraded ESSA Pharma (NASDAQ: EPIX) from Outperform to Perform.
Jefferies
$1.7
Hold
Downgraded
11/01/24
ESSA Pharma Faces Uncertainty After Discontinuing Masofaniten Programs, Receives Hold Rating
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bloom Burton Analyst forecast on EPIX
Bloom Burton
Bloom Burton
$2.25
Hold
Initiated
12/16/24
Bloom Burton Co. assumes ESSA Pharma (EPIX) at Hold (3)Bloom Burton Co. analyst David Martin assumes coverage on ESSA Pharma (NASDAQ: EPIX) with a Hold (3) rating and a price target of $2.25.
Piper Sandler Analyst forecast on EPIX
Piper Sandler
Piper Sandler
$15$2
Hold
Downgraded
11/04/24
ESSA Pharma Downgraded to Hold Amid Masofaniten Trial Termination and Revised Financial Outlook
Oppenheimer Analyst forecast on EPIX
Oppenheimer
Oppenheimer
Hold
Downgraded
11/03/24
Oppenheimer downgrades ESSA Pharma (EPIX) to PerformOppenheimer analyst Leland Gershell downgraded ESSA Pharma (NASDAQ: EPIX) from Outperform to Perform.
Jefferies
$1.7
Hold
Downgraded
11/01/24
ESSA Pharma Faces Uncertainty After Discontinuing Masofaniten Programs, Receives Hold Rating
Stocks with the Highest Top Analyst Consensus in the Sector
Find stocks in the sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ESSA Pharma

1 Month
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
3 Months
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
Dex GenotekTR | OpenAI - 4o
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a sell rating 10 months ago
Copying Dex Genotek's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
0/0 ratings generated profit
Average Return
0.00%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EPIX Analyst Recommendation Trends

Rating
Nov 24
Dec 24
Jan 25
Feb 25
Oct 25
Strong Buy
8
4
0
0
0
Buy
0
0
0
0
0
Hold
3
4
4
1
1
Sell
0
1
2
3
2
Strong Sell
0
0
0
0
0
total
11
9
6
4
3
In the current month, EPIX has received 0 Buy Ratings, 1 Hold Ratings, and 2 Sell Ratings. EPIX average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

EPIX Stock Forecast FAQ

What is EPIX’s average 12-month price target, according to analysts?
Currently, no data Available
What is EPIX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for EPIX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is EPIX a Buy, Sell or Hold?
      Currently, no data Available
      What is ESSA Pharma Inc.’s price target?
      Currently, no data Available
      What do analysts say about ESSA Pharma Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of EPIX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis